Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Laquinimod, an upcoming oral immunomodulatory agent for treatment of multiple sclerosis.
Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors.
Longitudinal MR Imaging of Iron in Multiple Sclerosis: An Imaging Marker of Disease.
Comparison of serum levels of copper and zinc among multiple sclerosis patients and control group.
A Patient-defined "Best Case" of Multiple Sclerosis Related to the Use of Complementary and Alternative Medicine.
Tumefactive idiopathic inflammatory demyelinating lesions: a diagnostic challenge.
The role of assessment in enhancing the vocational success of people with multiple sclerosis.
IL-17 and IL-17R: an auspicious therapeutic target for psoriatic disease.
Immunomodulatory characteristics of mesenchymal stem cells and their role in the treatment of Multiple Sclerosis.
iNKT-cells and their ligands: focus on multiple sclerosis.
Peroxisome proliferator activated receptor-γ agonists protect oligodendrocyte progenitors against tumor necrosis factor-alpha-induced damage: Effects on mitochondrial functions and differentiation.
The pill times 2: What every woman with multiple sclerosis should know.
Leukemia inhibitory factor tips the immune balance towards regulatory T cells in multiple sclerosis.
IL-15-secreting γδT cells induce memory T cells in experimental allergic encephalomyelitis (EAE) mice.
Tolerogenic vaccines for Multiple sclerosis.
Evaluation of reactive Epstein-Barr Virus (EBV) in Iranian patient with different subtypes of multiple sclerosis (MS).
Multiple sclerosis: Imaging of central veins in brain lesions can be used to predict multiple sclerosis.
Multiple sclerosis: autoimmunity and viruses.
Tolerance of intravenous methylprednisolone for relapse treatment in demyelinating CNS disease.
A Novel PET Imaging Probe for the Detection and Monitoring of Translocator Protein 18 kDa Expression in Pathological Disorders.
Neurology of inherited glycosylation disorders.
Patient assessment within the context of healthcare delivery packages: A comparative analysis.
Erratum to: Disentangling Multiple Sclerosis and depression: an adjusted depression screening score for patient-centered care.
miR-326 and miR-26a, two potential markers for diagnosis of relapse and remission phases in patient with relapsing-remitting multiple sclerosis.
Time matters - Acute stress response and glucocorticoid sensitivity in early multiple sclerosis.
Pages
« first
‹ previous
…
617
618
619
620
621
622
623
624
625
…
next ›
last »